newsfilter
← Latest News
Business Wire·

Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report

Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, 2026 (the